Logo

INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neu...

PLYMOUTH MEETING, Pennsylvania, May 20, 2020 /PRNewswire-AsiaNet/ -- -Publication in Nature Communications demonstrates generation of robust neutralizing antibodies and T cell responses against SARS-CoV-2 -Preliminary safety and immune responses data from Phase 1 clinical trial expected in June-Multip...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660